Speaker: Dr. Vandana Bandari

Title: Rheumatology Case of the Month

Date: August 19th, 2026

Time: 11:00am-11:30am

Location: D3240 - ASB 3rd Floor Conference Room

 

 

Session Learning Objectives:  Participants will (be able to):

1.  Differentiate TEN-like acute cutaneous lupus erythematosus from drug-induced SJS/TEN usingclinical, serologic, histopathologic, and medication-related features.

2.  Identify clinical and laboratory features that support active systemic lupus as a contributor to aTEN-like mucocutaneous eruption.

3.  Apply medication chronology, clinicopathologic findings, and current literature to the diagnosticand management approach for severe epidermal necrolysis in patients with SLE.

 

Speaker Disclosure Statement: Dr. Vandana Bandari in their role as [speaker] for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for this individual to be mitigated.  

 

Speaker Off-label Statement: Dr. Vandana Bandari will not be discussing the off-labeled, or investigational use of any product or device. 

 

Target Audience: Rheumatology Fellows and Faculty

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live activity for a maximum of _ 0.5 _ AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Directors & Planning Committee Disclosure Statement: Neither the activity director, the activity administrator, nor the planning committee members in their role as planning committee members for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for these individuals to be mitigated.

Commercial Support Statement: This CME activity has no commercial support associated with it.